Occupational allergy due to spider mites: Tetranychus urticae (Koch) and Panonychus citri (Koch) von BURCHES, E., PELAEZ, A., MORALES, C., BRASO, J.V., ROCHINA, A., LOPEZ, S., BENITO, M.

Volltext

Anaphylaxis to Erythromycin von Jorro, Gemma, Morales, Celia, Brasó, Jose Vicente, Peláez, Antonio

Volltext

Etiologic role of unapparent exposure in cat allergy von Brasó‐Aznar, J. V., Pelaez‐Hernandez, A., Rochina‐Puchades, A., Morales‐Rubio, C., Burches‐Baixauli, E.

Volltext

Mercurochrome allergy: concurrence of 2 hypersensitivity mechanisms in the same patient von Hernández, A. Peláez, Aznar, J. V. Brasó, Martínez, G. Jorro, Puchades, A. Rochina, Baixauli, E. Burches

Volltext

Occupational allergy due to spider mites : Tetranychus urtica (Koch) and Panonychus citri (Koch) von BURCHES, E, PELAEZ, A, MORALES, C, BRASO, J. V, ROCHINA, A, LOPEZ, S, BENITO, M

Volltext

Angioedema agudo en Urgencias von Brasó Aznar, José Vicente, Greco, Cristian

Volltext

Anaphylactoid reaction in relation to sialolithiasis von Martinez, G. Jorro, Aznar, J. V. Brasó, Rubio, C. Morales, Gil, J. V. Pascual, Hernandez, A. Peláez

Volltext

Deep venous thrombosis: present and future von Botella, F G, Labiós Gómez, M, Brasó Aznar, J V

Volltext

Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer von Villacampa, G., Tung, N.M., Pernas, S., Paré, L., Bueno-Muiño, C., Echavarría, I., López-Tarruella, S., Roche-Molina, M., del Monte-Millán, M., Marín-Aguilera, M., Brasó-Maristany, F., Waks, A.G., Pascual, T., Martínez-Sáez, O., Vivancos, A., Conte, P.F., Guarneri, V., Vittoria Dieci, M., Griguolo, G., Cortés, J., Llombart-Cussac, A., Muñoz, M., Vidal, M., Adamo, B., Wolff, A.C., DeMichele, A., Villagrasa, P., Parker, J.S., Perou, C.M., Fernandez-Martinez, A., Carey, L.A., Mittendorf, E.A., Martín, M., Prat, A., Tolaney, S.M.

Volltext

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer von Marín-Aguilera, M., Jares, P., Sanfeliu, E., Villacampa, G., Hernández-lllán, E., Martínez-Puchol, A.I., Shankar, S., González-Farré, B., Waks, A.G., Brasó-Maristany, F., Pardo, F., Manning, D.K., Abery, J.A., Curaba, J., Moon, L., Gordon, O., Galván, P., Wachirakantapong, P., Castillo, O., Nee, C.M., Blasco, P., Senevirathne, T.H., Sirenko, V., Martínez-Sáez, O., Aguirre, A., Krop, I.E., Li, Z., Spellman, P., Metzger Filho, O., Polyak, K., Michaels, P., Puig-Butillé, J.A., Vivancos, A., Matito, J., Buckingham, W., Perou, C.M., Villagrasa-González, P., Prat, A., Parker, J.S., Paré, L.

Volltext

79 (PB067): Identification of biomarkers of response and the mechanism of action of a selective androgen receptor modulator in estrogen receptorpositive breast cancer patient-deriv... von Monserrat, L., García, J. García, Gutiérrez, C. Molina, Viaplana, C., Brasó-Maristany, F., Bellet, M., Chandarlapaty, S., Nonell, L., Ponomarenko, J., Canals, F., Vicent, G. Pablo, Serra, V.

Volltext

153P HER2DX risk-score in the context of the PREDICT online-tool: A correlative analysis of the Short-HER clinical trial in early-stage HER2-positive (HER2+) breast cancer (BC) von Conte, P.F., Pare Brunet, L., Brasó-Maristany, F., Chic, N., Martinez Saez, O., Dieci, M.V., Marin, M., Guarneri, V., Vivancos, A., Villagrasa Gonzalez, P., Parker, J., Perou, C.M., Prat, A.

Volltext

25P Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial von Brasó-Maristany, F., Martinez Saez, O., Pare Brunet, L., Marín-Aguilera, M., Conte, P.F., Jares, P., Guarneri, V., Pascual, T., Puig-Butille, J.A., Vivancos, A., Parker, J., Villagrasa Gonzalez, P., Tolaney, S.M., Carey, L.A., Perou, C.M., Prat, A.

Volltext

237P HER2DX genomic assay in advanced HER2-positive (HER2+) breast cancer treated with T-DM1 von Brasó-Maristany, F., Griguolo, G., Chic, N., Pare Brunet, L., Galván, P., Dieci, M.V., Miglietta, F., Giarratano, T., Martínez-Sáez, O., Marin, M., Vidal Losada, M.J., Adamo, B., Munoz, M., Vivancos, A., Villagrasa Gonzalez, P., Parker, J., Perou, C.M., Conte, P.F., Prat, A., Guarneri, V.

Volltext

A case-control emergency department-based analysis of acute pancreatitis in Covid-19: Results of the UMC-19-S 6 von Miró, Òscar, Llorens, Pere, Jiménez, Sònia, Piñera, Pascual, Burillo-Putze, Guillermo, Martín, Alfonso, Martín-Sánchez, Francisco J, Lamberechts, Jorge, Alquézar-Arbé, Aitor, Jacob, Javier, Noceda, José, Cano Cano, María J, Fortuny Bayarri, María J, Marín Porrino, Juan M, Meléndez, Napoleón, Pérez García, Carles, Brasó Aznar, José V, Ponce, María C, Díaz Fernández, Elena, Ejarque Martínez, Laura, Peiró Gómez, Ana, Tost, Josep, Domínguez, María J, Teigell Muñoz, Francisco J, González Del Castillo, Juan

Volltext

119PERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine therap... von Chic, N, Pascual, T, Brasó-Maristany, F, Villagrasa Gonzalez, P, Pare Brunet, L, Schettini, F, Conte, B, Adamo, B, Vidal, M, Muñoz, M, Martínez, O, Gonzalez-Farre, B, Cortés, J, Llombart-Cussac, A, Rodrik-Outmezguine, V, Izquierdo Delso, M A, Schiff, R, Osborne, C K, Rimawi, M, Prat, A

Volltext

ERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine therapy (E... von Chic, N., Pascual, T., Brasó-Maristany, F., Villagrasa Gonzalez, P., Pare Brunet, L., Schettini, F., Conte, B., Adamo, B., Vidal, M., Muñoz, M., Martínez, O., Gonzalez-Farre, B., Cortés, J., Llombart-Cussac, A., Rodrik-Outmezguine, V., Izquierdo Delso, M.A., Schiff, R., Osborne, C.K., Rimawi, M., Prat, A.

Volltext

119P - ERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine the... von Chic, N., Pascual, T., Brasó-Maristany, F., Villagrasa Gonzalez, P., Pare Brunet, L., Schettini, F., Conte, B., Adamo, B., Vidal, M., Muñoz, M., Martínez, O., Gonzalez-Farre, B., Cortés, J., Llombart-Cussac, A., Rodrik-Outmezguine, V., Izquierdo Delso, M.A., Schiff, R., Osborne, C.K., Rimawi, M., Prat, A.

Volltext

1MO HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive breast cancer von Javierre, G. Villacampa, Cortés, J., García, J.M. Pérez, Cussac, A. Llombart, Tarantino, P., Conte, P.F., Mancino, M., Guarneri, V., Dieci, M.V., Waks, A., Brasó-Maristany, F., Pascual, T., Griguolo, G., Gonzalez, P. Villagrasa, Parker, J., Vivancos, A., Perou, C.M., Brunet, L. Pare, Prat, A., Tolaney, S.M.

Volltext

5P HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: An updated survival analysis von Saez, O. Martinez, Brasó-Maristany, F., Griguolo, G., Brunet, L. Pare, Dieci, M.V., Cortés, J., Cussac, A. Llombart, Villacampa, G., Marín-Aguilera, M., Rey, M., Goberna, G., Munoz, M., Vivancos, A., Gonzalez, P. Villagrasa, Parker, J., Conte, P.F., Prat, A., Pascual, T., Guarneri, V.

Volltext